Varda signs deal with Australian private spaceport operator to land its capsules
Blocked from landing its American-built space capsules by the American government, the startup Varda has now completed negotiations and signed an agreement with Southern Launch, an Australian private spaceport operator, to land its capsules at the Koonibba Test Range northwest of Adelaide.
Varda’s business plan is to launch unmanned capsules in which pharmeceuticals and other products that can’t be made on Earth are manufactured, then return the capsule to earth where they are sold for a profit. This deal will allow Varda to land its next capsule there in 2024.
Meanwhile, Varda first capsule, presently in orbit after manufacturing pharmeceuticals for HIV, appears to be a total loss because the FAA and the Pentagon refused it permission to land in the U.S., for what appear to be purely bureaucratic reasons.
There was no single specific issue that held up the reentry, he said. “It was ultimately a coordination problem amongst three different groups that had not worked through this operation before.” He added that there were no safety concerns with Varda’s spacecraft or its ability to meet requirements for an FAA license. An additional challenge is that Varda is the first company to seek an FAA reentry license through a new set of regulations called Part 450. Those regulations are intended to streamline the process but, on the launch side, have been criticized by companies for being difficult.
The U.S. government is now the enemy of its citizens, so incompetent that it actually works to block them from achieving their goals.
Blocked from landing its American-built space capsules by the American government, the startup Varda has now completed negotiations and signed an agreement with Southern Launch, an Australian private spaceport operator, to land its capsules at the Koonibba Test Range northwest of Adelaide.
Varda’s business plan is to launch unmanned capsules in which pharmeceuticals and other products that can’t be made on Earth are manufactured, then return the capsule to earth where they are sold for a profit. This deal will allow Varda to land its next capsule there in 2024.
Meanwhile, Varda first capsule, presently in orbit after manufacturing pharmeceuticals for HIV, appears to be a total loss because the FAA and the Pentagon refused it permission to land in the U.S., for what appear to be purely bureaucratic reasons.
There was no single specific issue that held up the reentry, he said. “It was ultimately a coordination problem amongst three different groups that had not worked through this operation before.” He added that there were no safety concerns with Varda’s spacecraft or its ability to meet requirements for an FAA license. An additional challenge is that Varda is the first company to seek an FAA reentry license through a new set of regulations called Part 450. Those regulations are intended to streamline the process but, on the launch side, have been criticized by companies for being difficult.
The U.S. government is now the enemy of its citizens, so incompetent that it actually works to block them from achieving their goals.
